Smart-Money SignalNeutral · 45/100— Insiders are net sellers over 90 days (-$758K, 3 sales vs 1 buy)
Revenue$2.0M
Net Income$38.3M
EPS$0.91
Gross Margin0.7%
Market Cap$173.9M
Price Performance
Historical data including institutional events
Company Profile
N
Nadav Kidron
CEO & Executive Director
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
